Oncotarget

Research Papers:

Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5

Franziska Zeeh, David Witte, Thomas Gädeken, Bernhard H. Rauch, Evelin Grage-Griebenow, Nadja Leinung, Sofie Joline Fromm, Stephanie Stölting, Koichiro Mihara, Roland Kaufmann, Utz Settmacher, Hendrik Lehnert, Morley D. Hollenberg and Hendrik Ungefroren _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:41095-41109. https://doi.org/10.18632/oncotarget.9600

Metrics: PDF 1050 views  |   HTML 1511 views  |   ?  


Abstract

Franziska Zeeh1,*, David Witte1,*, Thomas Gädeken1, Bernhard H. Rauch2, Evelin Grage-Griebenow1, Nadja Leinung1, Sofie Joline Fromm1, Stephanie Stölting1, Koichiro Mihara3, Roland Kaufmann4, Utz Settmacher4, Hendrik Lehnert1, Morley D. Hollenberg3 and Hendrik Ungefroren1

1 First Department of Medicine, University of Lübeck, Lübeck, Germany

2 Department of General Pharmacology, Institute of Pharmacology, University Medicine Greifswald, Greifswald, Germany

3 Department of Physiology & Pharmacology and Department of Medicine, Inflammation Research Network-Snyder Institute for Chronic Diseases, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada

4 Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany

* These authors have contributed equally to this work

Correspondence to:

Hendrik Ungefroren, email:

Keywords: TGF-β; PAR2; ALK5; signalling; cell motility

Received: April 20, 2016 Accepted: May 14, 2016 Published: May 27, 2016

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by high expression of transforming growth factor (TGF)-β and the G protein-coupled receptor proteinase-activated receptor 2 (PAR2), the latter of which functions as a cell-surface sensor for serine proteinases asscociated with the tumour microenvironment. Since TGF-β and PAR2 affect tumourigenesis by regulating migration, invasion and metastasis, we hypothesized that there is signalling crosstalk between them. Depleting PDAC and non-PDAC cells of PAR2 by RNA interference strongly decreased TGF-β1-induced activation of Smad2/3 and p38 mitogen-activated protein kinase, Smad dependent transcriptional activity, expression of invasion associated genes, and cell migration/invasion in vitro. Likewise, the plasminogen activator-inhibitor 1 gene in primary cultures of aortic smooth muscle cells from PAR2-/- mice displayed a greatly attenuated sensitivity to TGF-β1 stimulation. PAR2 depletion in PDAC cells resulted in reduced protein and mRNA levels of the TGF-β type I receptor activin receptor-like kinase 5 (ALK5). Forced expression of wild-type ALK5 or a kinase-active ALK5 mutant, but not a kinase-active but Smad-binding defective ALK5 mutant, was able to rescue TGF-β1-induced Smad3 activation, Smad dependent transcription, and cell migration in PAR2-depleted cells. Together, our data show that PAR2 is crucial for TGF-β1-induced cell motility by its ability to sustain expression of ALK5. Therapeutically targeting PAR2 may thus be a promising approach in preventing TGF-β-dependent driven metastatic dissemination in PDAC and possibly other stroma-rich tumour types.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9600